Cipla — Invagen Pharmaceuticals
Tracked across 1 events · 6 articles · First seen Sep 03, 2026 · Last active Sep 04, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: Invagen, Cipla's wholly owned US subsidiary, is the direct party to the licensing agreement and will lead commercialization in the US.
Sep 03, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Cipla — Invagen Pharmaceuticals live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard